Home/Filings/4/0000882796-25-000036
4//SEC Filing

Gayer Charles K 4

Accession 0000882796-25-000036

CIK 0000882796other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 4:21 PM ET

Size

4.7 KB

Accession

0000882796-25-000036

Insider Transaction Report

Form 4
Period: 2025-12-12
Gayer Charles K
Vice President and CCO
Transactions
  • Tax Payment

    Common Stock

    2025-12-12$7.57/sh8,181$61,930418,827 total
Footnotes (1)
  • [F1]Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted restricted stock units. This transaction does not represent a sale by the reporting person.

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1
  • filerCIK 0001800110

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:21 PM ET
Size
4.7 KB